Poxel is a biopharma company developing innovative drugs for metabolic diseases, in particular Type 2 diabetes.
Poxel is a biopharma company developing innovative drugs for metabolic diseases, in particular Type 2 diabetes.
Biocon, India’s largest biotech company, is focused on delivering affordable innovation by leveraging India’s cost advantage to reduce therapy costs of chronic diseases like diabetes, cancer and autoimmune diseases.